SHR-2906
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 15, 2026
A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
(clinicaltrials.gov)
- P1 | N=124 | Recruiting | Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Not yet recruiting ➔ Recruiting | N=84 ➔ 124
Enrollment change • Enrollment open • Genetic Disorders • Obesity
December 16, 2025
A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
(clinicaltrials.gov)
- P1 | N=84 | Not yet recruiting | Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
New P1 trial • Genetic Disorders • Obesity
1 to 2
Of
2
Go to page
1